腔内修复术治疗肾下型腹主动脉瘤合并糖尿病的中远期疗效观察  

Mid- and long-term follow up of endovascular aortic repair for infrarenal abdominal aortic aneurysms with diabetes mellitus

作　　者：孙国义[1] 刘杰[1] 贾鑫[1] 贾森皓[1] 张敏宏[1] 许永乐[1] 张宏鹏[1] 马晓辉[1] 熊江[1] 刘小平[1] 郭伟[1] Sun Guoyi;Liu Jie;Jia Xin;Jia Senhao;Zhang Minhong;Xu Yongle;Zhang Hongpeng;Ma Xiaohui;Xiong Jiang;Liu Xiaoping;Guo Wei.(Department of Vascular Surgery, People＇s Liberation Army General Hospital ,Beijing 100853, China)

机构地区：[1]解放军总医院血管外科,北京100853

出　　处：《中华普通外科杂志》2018年第6期470-472,共3页Chinese Journal of General Surgery

摘　　要：目的观察腔内修复术（EVAR）治疗肾下型腹主动脉瘤（AAA）合并糖尿病（DM）患者的临床疗效，并分析影响中远期疗效的因素。方法对2004年1月至2014年6月符合纳入标准的103例AAA合并DM患者行EVAR治疗并进行随访。结果88例（85．43％）患者完成最终有效随访，中位随访时间3．59年，最长随访时间10．32年。随访期间共发生25例死亡，远期全因死亡率为24．3％。随访期间共发生介人相关并发症6例（5．8％）。随访期问二次干预2例，二次干预率为1．9％。术后5年累积生存率为70％，术后10年累积生存率为6l％。结论EVAR手术对AAA合并DM患者是安全的。Objective To evaluate the outcome of the endovascular aortic repair （EVAR） of abdominal aortic aneurysms （AAA） with diabetes mellitus （DM） and analyze the factors that influence its mid-long-term curative effect. Methods From Jan 2004 to Jun 2014 ,follow-up data of 103 AAA patients with DM treated with EVAR was analyzed retrospectively. Results Effective follow-up visits were conducted on 88 patients （ 85. 43% ）. The patients were tracked for an median of 3.59 years, with the longest follow-up 10. 32 years. 25 deaths occurred and the all-cause mortality rate was 24. 3%. 6 eases had intervention-related complications （ 5.8% ） , including endoleaks, thrombosis, embolism, infection, false aneurysms. 2 secondary interventions were conducted on 2 patients. The five-year cumulative survival rate was 70% and the ten-year cumulative survival rate was 61%. Conclusion EVAR is safe for AAA patients with DM.

关 键 词：主动脉瘤 腹部 支架 糖尿病 治疗效果 

分 类 号：R543.16[医药卫生—心血管疾病] R587.1[医药卫生—内科学]